All You Need to Know About AVITA Medical, Inc. (RCEL) Rating Upgrade to BuyZacks Investment Research • 04/14/21
15 RECELL® System Abstracts Accepted for Presentation at 53ʳᵈ Annual American Burn Association MeetingGlobeNewsWire • 03/30/21
Avita Medical, Inc. Announces Closing of Offering of 3,214,250 Shares of Common StockGlobeNewsWire • 03/01/21
AVITA Therapeutics, Inc. (RCEL) CEO Mike Perry on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/12/21
AVITA Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceGlobeNewsWire • 02/03/21
AVITA Medical to Present at the J.P. Morgan 39th Annual Healthcare ConferenceGlobeNewsWire • 12/28/20
AVITA Therapeutics to Participate at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/18/20
AVITA Therapeutics, Inc. (RCEL) CEO Michael Perry on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/11/20
AVITA Therapeutics, Inc. (RCEL) CEO Michael Perry On Q3 2020 Results - Quick Version Earnings Call Transcript.Seeking Alpha • 11/10/20
Avita Therapeutics, Inc. Announces Correction of Time for the Adjourned 2020 Annual Stockholder MeetingGlobeNewsWire • 11/05/20
AVITA Therapeutics Announces Date Change for First Quarter 2021 Earnings Release and Conference CallGlobeNewsWire • 11/03/20
AVITA Therapeutics, Inc. Announces Adjournment of 2020 Annual Stockholder MeetingGlobeNewsWire • 10/29/20